The HemAway Seat(R) offers relief for sufferers of prolapsed internal hemorrhoids
BERKELEY HEIGHTS, N.J., March 12 /PRNewswire/ -- HemAway(R) (www.HemAway.com) announced today the launch of its first FDA-cleared consumer product, the HemAway Seat(R), a painless, non-invasive, discreet, and easy-to-use hemorrhoid treatment device that alleviate the discomfort and agony of prolapsed internal hemorrhoids within minutes of use.
Fitted for seamless and discreet installation on most toilet models, the HemAway Seat naturally uses one's body weight to allow the prolapsed internal hemorrhoid to gently withdraw back into the body, relieving pain, discomfort, and irritation.
HemAway is the brainchild of founder and developer Dr. John Maurello, a practicing chiropractor and long-time sufferer of internal hemorrhoids that would not respond to available treatments and surgery. He created the HemAway Seat upon making a life-changing discovery that eliminated the discomfort of his debilitating condition and allowed him to reclaim his quality of life. "Once I realized its efficacy, I knew the seat would prove to be a welcomed relief for the millions of hemorrhoid sufferers seeking a simple, painless, effective solution to help heal and manage their condition," states Dr. Maurello.
The HemAway Seat fills an urgent need for millions of sufferers who seek alternatives to the few available treatments for internal hemorrhoids. Hemorrhoid creams and home remedies are marginally helpful and at best reduce swelling or mask the pain of the condition. Invasive procedures are the only other available therapies and force patients to face the risks of hemorrhoid surgeries such as permanent incontinence. Dr. Maurello adds, "There is a void for effective treatments that are non-invasive and risk-free."
Approximately half of all Americans experience hemorrhoids by the age of 50 [source: NIH] and 70 percent of women suffer from hemorrhoids at some point during pregnancy or after delivery. [source: Francis-Cheung, Theresa. Pregnancy Weight Management. Adams Media, 2000, p.124.] According to one clinical study, 41 percent of advanced-stage hemorrhoid sufferers were unsatisfied with the results of surgical removal. [source: Surg Endosc. 2008 Nov; 22(11):2379-83. Epub 2008 Jul 12.] These hemorrhoid statistics clearly indicate the need for a product like the HemAway Seat that effectively treats chronic hemorrhoids so that drastic and painful invasive procedures can be avoided and helps sufferers manage the condition when surgical treatments fail.
The HemAway Seat is available for purchase at HemAway.com in both home ($199) and travel models ($129).
Founded by serial entrepreneurs and seasoned medical professionals in 2007, HemAway(R) is a medical device company based in Berkeley Heights, NJ with a mission to develop and market innovative products to meet common medical problems. In early 2009, HemAway launched its first consumer product, the HemAway Seat(R). Cleared for marketing by the FDA, the HemAway Seat was developed specifically to bring relief to the sufferers of prolapsed internal hemorrhoids. HemAway supports American businesses by insuring all products are designed and manufactured in the US. For more information, visit www.HemAway.com.
CONTACT: Esther Koo of Southard Communications for HemAway,
Web site: http://www.HemAway.com/